From Surf Wiki (app.surf) — the open knowledge base

Risedronic acid

Chemical compound

| Drugs.com =

| elimination_half-life = 1.5 h

Risedronic acid, often used as its sodium salt risedronate sodium, is a bisphosphonate. It slows down the cells which break down bone. It's used to treat or prevent osteoporosis, and treat Paget's disease of bone. It is taken by mouth.

It was patented in 1984 and approved for medical use in 1998.

Pharmacology

Bisphosphonate	Relative potency
Etidronate	1
Tiludronate	10
Pamidronate	100
Alendronate	100-500
Ibandronate	500-1000
Risedronate	1000
Zoledronate	5000

History

Risedronate, known as NE-58095 while under development, was discovered by scientists at the Cincinnati Miami Valley Laboratories and the Norwich Eaton Laboratories of Procter and Gamble.

Society and culture

Brand names

It is produced and marketed by Warner Chilcott, Sanofi-Aventis, and in Japan by Takeda under the trade names Actonel, Atelvia, and Benet. It is also available in a preparation that includes a calcium carbonate supplement, as Actonel with Calcium.

Controversies

In January 2006 P&G and its marketing partner Sanofi-Aventis filed a Lanham Act false claims lawsuit against rival drugmakers Roche and GlaxoSmithKline claiming false advertising about Boniva. The manufacturers of Boniva, a rival bisphosphonate, were accused in the suit of causing a "serious public health risk" through misrepresentation of scientific findings. In a ruling on September 7, 2006, U.S. District Judge Paul A. Crotty rejected P&G's attempted injunction. P&G was criticized for attempting to "preserve its market share by denigrating Boniva". Judge Crotty wrote that "Roche was clearly entitled to respond with its own data, provided that the data was truthfully and accurately presented".

In 2006, P&G faced controversy over its handling of clinical research involving risedronate (News Reports and discussion).

In common with other bisphosphonate drugs, risedronate appears to be associated with the rare side effect osteonecrosis of the jaw, often preceded by dental procedures inducing trauma to the bone.

References

(1 November 2019). "Actonel- risedronate sodium tablet, film coated".
(2006). "Analogue-based Drug Discovery". John Wiley & Sons.
(30 September 2013). "Essentials of medical pharmacology". Jaypee Brothers Medical Publishers Ltd..
(August 2020). "History of risedronate". Bone.
"P&G Press statement". Uk.pg.com.
(8 September 2006). "Boniva advertising 'not misleading' says US judge". Pharma Times.
"Actonel Case Media Reports". Scientific Misconduct Wiki.
"Scientific Misconduct Blog". Scientific-misconduct.blogspot.com.

Info: Wikipedia Source

This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.

bisphosphonates farnesyl-pyrophosphate-synthase-inhibitors procter-&-gamble 3-pyridyl-compounds drugs-developed-by-abbvie sanofi drugs-developed-by-takeda-pharmaceutical-company

Want to explore this topic further?

Ask Mako anything about Risedronic acid — get instant answers, deeper analysis, and related topics.

Research with Mako

Free with your Surf account

Content sourced from Wikipedia, available under CC BY-SA 4.0.

This content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.

Report